Redox homeostasis, bioactive agents and transduction therapy

Current Signal Transduction Therapy

Volumn 2, Issue 3, 2007, Pages 226-239

  Blázovicz, Anna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Free radicals; Natural antioxidants; Redox homeostasis; Signal transduction

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATECHIN; CELL ADHESION MOLECULE; CYTOKINE; DNA; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FLAVONOID; FREE RADICAL; GREEN TEA EXTRACT; ISOTHIOCYANIC ACID DERIVATIVE; LIGAND; PHOSPHOTRANSFERASE; PHYTIC ACID; PLACEBO; POLYPHENOL DERIVATIVE; PROSTAGLANDIN; RECEPTOR; RETINOL; SULFORAPHANE; TANNIN DERIVATIVE; TAXIFOLIN; TRACE ELEMENT; TRANSCRIPTION FACTOR; UNINDEXED DRUG;

ALCOHOL LIVER CIRRHOSIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLON CARCINOMA; CYTOTOXICITY; DNA SYNTHESIS; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG OVERDOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HEMOLYTIC ANEMIA; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; STROKE;

EID: 34848893866     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436207781745364     Document Type: Review

References (261)

1. Halliwell B, Gutteridge JMC. Editors, Free radicals in biology and medicine, Clarendon Press, Oxford 1996.
2. Kamata H, Hirata H. Redox regulation of cellular signaling. Cell Signal 1999; 11: 1-14.
3. Factor VM, Kiss A, Woitach JT, Wirth PJ, Thorgeirsson SS. Disruption of redox homeostasis in the transforming growth factor-α/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J Biol Chem 1998; 273: 15846-53.
4. Szentmihályi K, Blázovics A, Lugasi A, Kéry Á, Lakatos B, Vinkler P. Effect of natural polyphenol-type antioxidants (Sempervivum tectorum and Raphanus sativus L. var. niger extracts) on metal ion concentrations in rat bile fluid. Curr Top Biophys 2000; 24: 203-07.
5. Atmane N, Dairou J, Paul A, Dupret JM, Rodrigues-Lima. F. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide. J Biol Chem 2003; 278: 35086-92.
6. Haddad JJ. Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines Cell Mol Ther 2002; 7: 1-14.
7. Malaguarnea L, Ferlito L, Imbesi RM, et al. Immunosenescence: a review. Arch Gerontol Geriat 2001; 32: 1-4.
8. Goodwin JS. Am Prostaglandins proinflammatory, antinflammatory, both or neither. J Rheumatol 1991; (Suppl 28) 18: 26-29.
9. 2 receptor expression. Hum Immunol 2000; 61: 684-96.
10. Rocca B, Fitzgerald GA. Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmcol 2002; 2: 603-30.
11. Nelson NA, Kelly RC, Johnson RA. Upjohn Co Prostaglandins and the arachidonic acid cascade. Special Report C and EN, 1982.
12. Van der Oudema FJ, Buytenhek M, Nugteren DH, Van-Dorp DA. Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands. Biochim Biophys Acts 1997; 487: 315-31.
13. Smith WL. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 2005; 17: 174-82.
14. Sugimoto Y, Narumija A, Ichikawa A. Distribtion and function of prostanoid receptors: studies from knockout mice. Prog Lipid Res 2000; 39: 289-14.
15. Bhattacharya M, Peri K, Ribeiro-da-Silva A, et al. Localization of functional progtaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 1999; 28: 15719-24.
16. Salvemini D, Misko TP, Masferrer JL, et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-44.
17. Hughes FJ, Buttery LDK, Hukkanen MVJ, O'Donnel A, Maclouf J, Polak JM. Cytokine-induced prostaglandin E2 synthesis and cyclooxyǵenase-2 activity are regulated both by nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 1999; 274: 1776-82.
18. Pace-Asciak CR, Asotra S. Biossynthesis, catabolis, and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radic Biol Med 1989; 7: 409-33.
19. Samuelsson B, Goldyne M, Granström E, Hamberg M, Hammarström S, Malmsten C. Prostaglandins and tromboxanes. Ann Rev Biochem 1978; 47: 997-29.
20. Samuelsson B. Leucotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-75.
21. Bach MK, Brashler JR, Hammarstrom S, Samuelson B. Identification of leukotriene c-1 as a major component of slow-reacting substance from rat mononuclear cells. J Immunol 1980; 125: 115-17.
22. Bach MK, Brashler JR, Hammarstrom S, Samuelson B. Identification of a component of rat mononuclear cell SRS as leukotriene D. Biochem Biophys Res Commun 1980; 93: 1121-26.
23. Shimizu T, Izuimi T, Seyama Y, Tadokoro K, Radmark O, Samuelson B. Characterization of leucotriene A4-synthase from murine mast cells, Evidence for its identity to arachidonate 5-lypoxigenase. Poroc Natl Acad Sci USA 1986; 183: 4175-79.
24. Polya GM, Polya Z, Kweifio-Okai G. Biochemical pharmacology of anti-inflammatory plant secondary metabolites In: Sighn E, Govil J N, Sighn VK Eds. Recent Progress in Medicinal Plants, SCI TECH Publishing, Houston, Texas, USA 2002; 9: 1-22.
25. Ghosh J. Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase. Biochem Biophys Res Commun 2003; 307: 342-49.
26. Narumiya S, Fukushima M. Site and mechanism of growth inhibition by prostaglandins 1. Active transport and intracellullar accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther 1996; 239: 500-05.
27. Noguchi K, Iwasaki K, Shitashige M, et al: Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts. Inflammation 2001; 25: 75-81.
28. Iwasaki K, Noguchi K, Endo H, Kondo H, Ishikawa I. Prostaglandin E2 downregulates interleukin-12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon-gamma. Oral Microbiol Immunol 2003; 18: 150-55.
29. 3 and FP prostanoid receptors are involved. Int Immunopharmacol 2003; 3: 865-68.
30. Harris SG, Padilla J, Koumas L, RayD, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 3144-50.
31. Head KA, Jurenka JS. Inflammatory Bowel Disease Part I. Ulcerativ colitis-pathophysiology and conventional and alternative treatment options. Altem Med Rev 2003; 8: 247-83.
32. Jozkowicz A, Dulak J, Prager M, et al. Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner. Prostaglandins Other Lipid Mediat 2001; 66: 165-7.
33. McKenźie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996; 98: 136-41.
34. Pavlick KP, Laroux FS, Fuscler J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002; 33: 311-12.
35. Ramachandiran S, Huang Q, Dong J, Lau SS, Monks TJ. Mitogen activated protein kinases contribute to reactive oxygen species-induced cell death in renal proximal tubule epithelial cells. Chem Res Toxicol 2002; 15: 1635-42.
36. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-κB activation by MAP kinase cascades. Immunbiology 1997; 198: 35-9.
37. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor. EMBO J 1993; 12: 2005-15.
38. Meyer M, Pabl HL, Baeuerle PA. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem Biol Interact 1994; 91: 91-100.
39. Lander HM, Ogiste JS, Teng KK, Novogrodsky A. p2lras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 1995; 270: 21195-98.
40. Powis G, Gasdanska JR, Baker A. Redox signaling and the control of cell growth and death. Adv Pharmacol 1997; 38: 329-58.
41. Accaoui MJ, Enoiu M, Mergny M, et al. Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-κB. Biochem Biophys Res Commun 2000; 276: 1062-67.
42. Sekhar KR, Spitz DR, Harris S, et al. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. Free Radic Biol Med 2002; 32: 650-52.
43. Abate C, Patel L, Rauscher IFJ, Curran T. Redox regulation of Fos and Jun DNA: binding activity in vitro. Science 1990; 249: 1157-61.
44. Wild AC, Mulcahy RT. Regulation of gamma-glutamylcysteine synthetase subunit gene expression: Insights into transcriptional control of antioxidant defenses. Free Radic Res 2000; 32: 281-01.
45. Thompson CB, Apoptosis in the pathogenesis and treatment of disease. Science 1995 267: 1456-62.
46. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-76.
47. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-90.
48. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-24.
49. Petit PX, Susin SA, Zamzami N. Mitochondria and programmed cell death: back to the future. FEBS Lett 1996; 963: 7-13.
50. Sheikh MS, Fornace AJ Jr. Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000; 14: 1509-13.
51. Kudrin AV. Trace elements in regulation of NF-κB activity. J Trace Elem-Med Biol 2000; 14: 129-42.
52. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22: 269-85.
53. Karin M. How NF-κB is activated: the role of the IκB kinase (IKK')complex. Oncogene 1999; 18: 6867-74.
54. Kopner L, Fésus L, Apoptózis, Medicina, Budapest 2002.
55. Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. The proteasome. Annu Rev Biophys Biomol Struct 1999; 28: 295-17.
56. Hasselgren PO, Fischer JE. The Ubiquitin-Proteasome Pathway: Review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg 1997; 225: 307-16.
57. Orlowski RZ. The role at the ubiquitin-proteasome pathwayin apoptosis. Cell Death Diff l999; 6: 303-13.
58. Ciechanover A, Orian A, Schwartz AL. Ubiquitin mediated proteolysis: biological regulation via destruction. Bioassay 2000; 22: 442-51.
59. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998; 16: 395-19.
60. Kumar S: Mechanisms mediating caspase activation in cell deth. Cell Death Differ 1999; 6: 1060-66.
61. de Murcia G, Menissier-de Murcia J. Poly (ADP-ribose)-polymerase: a molecular nick sensor. Trends Biochem Sci 1994; 19: 172-76.
62. Le Rhun Y, Kirkland JB, Shah GM. Cellular responses to DNA damage in the absence of poly (ADP-Tibosey polymerase. Biochim Biophys Res Common 1998; 245: 1-110.
63. Szabó C, Dawson VL. Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19: 287-98.
64. Andrási TB, Blázovics A, Szabó G, Vahl CF, Hagl S. Poly (ADP-ribose) polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest. Am J Physiol Heart Circ Phys 2005; 288: H2972-78.
65. Szabó VL, Bakondi E, Bai P, Gergely P, Hunyadi J, Szabó C. Nitric oxide-peroynitrite-poly(ADP-ribose) polymerase pathway in the skin. Exp Dermatol 2002; 11: 189-02.
66. Horbinski C, Chu CT. Mouse signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med 2005; 38: 2-11.
67. Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med 2004; 25: 17-26.
68. Bakin AV, Stourman NV, Sekhar KJ, et al. Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying ptroteins. Free Radic Biol Med 2005; 38: 375-87.
69. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKCε and MAPK form signaling modules in the murine heart (Enhanced mitochondrial and differential MAPK activation in PKCε-induced cardioprotection. Circ Res 2002; 90: 390-97.
70. Robinson-White A, Stratakis CA. Protein kinase A signaling "cross-talk" with other pathways in endocrine cells. Ann NY Acad Sci USA 2002; 968: 256-70.
71. Technikova-Dubrova Z, Sardenelli AM, Speranza F, et al. Cyclic adenosine monophosphate dependent phosphorilation of mammalian mitochonfrial proteins: enzyme and substrate characterization and functional role. Biochemistry 2001; 40: 13941-47.
72. Ginsberg MD, Feliciello A, Jones JK, Avvedimento EV, Gottesman ME. PKA-dependent binding of mRNA to the mitochondial AKAP121 protein. J Mol Biol 2003; 327: 885-97.
73. Datta SR, Dudek HTX, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997; 91: 231-41.
74. Majewski M, Nieborowska-Skorska M, Salomoni P, et al. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. Cancer Res 1999; 59: 2815-19.
75. Dempsey EC, Newton AC, Mochly-Rosen D, et al. Protein kinase C isoenzymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279: L429-38.
76. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med 2000; 28: 1349-61.
77. Mochly-Rosen D, Gordon AS. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 1998; 12: 35-42.
78. Numazawa S, Ishikawa M, Yoshida A, et al. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Phys Cell Physiol 2003; 285: c334-42.
79. Huang HC, Nguyen T, Pickett CB. Phosphorilation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002; 277: 42769-74.
80. McCord JM. The evolution of free radicals and oxidative stress. Am J Med 2000; 108: 652-59.
81. Leonarduzzi G, Robbesyn F, Poli G. Signling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004; 37: 1694-02.
82. Yang Y, Sharma R, Sharma A, Awasthi S, Awasthi YC. Lipid peroxidation and cell signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 2003; 50: 319-36.
83. Chiarpotto B, Domenicotti C, Paola D, et al. Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4-hydroxy-2,3 nonenal. A signaling pathway to modulate vesicular transport of glycoroteins. Hepatology 1999; 29: 1565-72.
84. Parola M, Robino G, Marra F, et al. HNE interacts directly with JNK isoforms I human hepatic stellate cells. J Clin Invest 1998; 102: 1942-50.
85. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signaling. Curr Med Chem 2004; 11: 1163-82.
86. Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco BD. Oxidative neuronal injury:the darkside of ERK1/2. Eur J Biochem 2004; 271: 2060-04.
87. Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathwayin regulation of adaptive respons to electrophiles. Free Radic Biol Med 2004; 36: 1208-13.
88. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-12.
89. Zhang J, Gao JX, Salojin K, et al. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. Exp Med 2000; 19: 1017-30.
90. Dickens M, Rogers JS, Cavanagh J, et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997; 277: 693-96.
91. Wang T, Arifoglu P, Ronai Z, Tew KD. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 2001; 276: 20999-1003.
92. Crowe DL, Tsang KJ, Shemirani B. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 2001; 3: 27-32.
93. Das KC. c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation. J Biol Chem 2001; 276: 4662-70.
94. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFα-induced apoptosis. Cell 2003; 115: 61-70.
95. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 2003; 23: 7198-09.
96. Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondial conversation in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 2004; 25: 259-64.
97. Saelens X, Festjens N, Walle LV, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004; 25: 259-64.
98. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. J Biol Chem 1991; 266: 11632-39.
99. Kang KW, Lee SJ, Park JW, Kim SG. Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol Pharmacol 2002; 62: 1001-10.
100. Yu R, Chen C, Mo YY, et al. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 2000; 275: 39907-13.
101. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant responsive elements. Biochem Biophys Res Commun 1997; 236: 313-22.
102. Ishii T, Itoh K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000; 275: 16023-29.
103. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and cFos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc Natl Acad Sci USA 1996; 93: 14960-65.
104. Kong AN, Owuor E, Yu R, et al. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Res 2001; 33: 255-71.
105. Dhakshinamoorthy S, Jaiswal AK. Functional characterization and role of Inrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 2001; 20: 3906-17.
106. Itoh K, Wakabayashi N, Katoh Y, Ishii T, O'Connor T, Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shutting and degradation of Nrf2 in response to electrophiles. Genes Cells 2003; 8: 379-91.
107. McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of ARE-driven gene expression. J Biol Chem 2003; 278: 21592-600.
108. Talalay P, Dinkova-Kostova AT, Holtzclaw WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 2003; 43: 121-34.
109. Friling RS, Bensimon S, Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA 1990; 87: 6258-62.
110. Keum YS, Jeong WS, Kong AN. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanism. Murat Res 2004; 555: 191-02.
111. Szentmihályi K, Csiktusnádi-Kiss GA, Keszler Á, et al. Method development for measurement of elements in Hungarian red wines by inductively coupled plasma optical emission spectrmetry (ICP-OES). Acta Aliment (Hung) 2000b: 29: 105-21.
112. Szentmihályi K, Then M. Teas of Equiseti herba, Myrtilli folium and Salviae folium. Acta Aliment (Hung) 2000; 29: 43-49.
113. Máday E, Szentmihályi K, Then M, Szoke É. Mineral element content of chamomile. Acta Aliment (Hung) 2000; 29: 51-57.
114. Stefanovits-Bányai É, Szentmihályi K, Hegedus A, et al. Metal ion and antioxidant alterations in leaves between different genders of Ginkgo biloba L (Ginkgoaceae). Life Sci 2005; 78: 1049-56.
115. Yuregir GT, Kayrin L, Curuk MA, Acarturk E, Unlukurt I. Correlation between trace elements and lipid profiles J Trace Elem Exp Med 1994/ 1995; 7: 113-8.
116. Schroeder JJ, Cousins RJ. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci USA 1990; 87: 3137-31.
117. Higinbothan KG, Rice JM, Diwan BA, Kasprzak KS, Reed CD, Perantoni AO. GGT to GTT transversions in codon 12 of the K-ras onco gene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res 1992; 52: 4747-51.
118. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18: 321-36.
119. Blázovics A, Abaza M, Sípos P, Szentmihályi K, Fehér E, Szilágyi M. Biochemical and morphological changes in liver and gallbladder bile of broiler chicken exposed to heavy metals (cadmium, lead, mercury). Trace Elem Electrolytes 2002; 19: 42-47.
120. Blázovics A, Szentmihályi K, Vinkler P, Kovács Á.: Zn overdose may cause disturbance in the iron metabolism. Trace Elem Electrolytes 2003; 20: 10-6.
121. Dinkova-Kostova AT, Holtzclaw WD, Wakabayashi N. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 2005; 44: 6889-99.
122. Kasprzak KS, Waalkes MP, Poirier LA. Effect of essential divalent metals on carcinogenicity and metabolism of nickel and cadmium. Biol Trace Elem Res 1987 13: 253-73.
123. Ferruzza S, Scarino ML, Rotilio G, et al. Copper treatment alters the permeability of tight junction in culured human intestinal Caco-2 cells. Am J Physiol 1999; 277: G1138-48.
124. Floris G, Medda R, Padiglia A, et al. The physiopathological significance of ceruloplasmin. A possible therapeutic approach. Biochem Pharmacol 2000; 60: 1735-41.
125. Pena MM, Lee J, Thiele DJ. A delicate balance: homeostatic control of copper uptake and distribution. J Nutr 1999; 129: 1251-60.
126. Brando-Neto J, Stefan V, Mendonca BB, et al. The essential role of zinc in growth. Nutr Res 1995; 15: 335-38.
127. Chen CY, Huang YL, Lin TH. Association between oxidative stress and cytokine production in nickel-treated rats. Arch Biochem Biophys 1998; 356: 127-32.
128. Chion WL. Ferrosulphate bioavailability monograph. J Am Pharm Assoc 1977; 17: 337-80.
129. Lakatos B, Szentmihályi K, Sándor Z, Vinkler P. A nyomelemek szerepe az erythropoesisben és a vas metabolizmusában (Role of trace elements in erythropoesis and iron methabolism). Gyógyszerészet. (Pharmaceutics) 97; 41: 424-30.
130. Sigel A, Sigel H. Interactions between Free Radicals and Metal Ions in Life Processes. Metal Ions in Biological Systems, Marcel Dekker Inc., New York 1999; 36: 1-797.
131. +2 exhibits dynamic binding to multiple ligands in human plazma. Metab Clin Exp 1992; 41: 1087-92.
132. Sigel A, Sigel H. Manganese and its Role in Biological Processes. Metal Ions in Biological Systems, Marcel Dekker Inc., New York 1999; 37: 1-788.
133. Schramm VL, Wedler FC. Manganese in metabolism and enzyme function. Acad Press, New York 1986; 1-437.
134. Maehle L, Metcalf RA, Ryberg D, Bennett WP, Harris CC, Haugen A. Altered p53 gene structure and expression in human epithelia cells after exposure to nickel. Cancer Res 1992; 52: 218-21.
135. Kernohan NM. Hupp TR, Lane DP. Modification of an N-terminal regulatory domain of T antigen restores P53-T antigen complex formation in the absence of an essential metal ion cofactor. J Biol Chem 1996; 271: 4954-60.
136. Chukhlovin AB, Tokalov SV, Yagunov, AS, Westendorf J, Reincke H, Karbe L. In vitro suppression of thymocyte apoptosis by metal-rich complex environmental mixtures: potential role of zinc and cadmium excess. Sci Total Environ 2001; 281: 153-63.
137. Veness-Meehan KA., Cheng ER, Mercier CE, et al. Cell-specific alterations in expression of hyperoxia-induced mRNA of lung. Am J Respir Cell Mol Biol 1991; 5: 516-21.
138. Liu J, Kershaw WC, Klaassen CD. The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture. Toxicol Appl Pharmacol 1991; 107: 27-34
139. Mercer JFB, Stevenson T, Wake SA, et al. Developmental variation in copper, zinc and metallothionein mRNA in brindled mutant and nutritionally copper deficient mice, Biochim. Biophys. Acta Mol Basis Dis 1991; 1097: 205-11.
140. Mulder TP, van der Sluys Veer A, Verspaget HW, et al. Effect of oral zink supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol 1994; 9: 472-77.
141. Viarengo A, Burlando B, Ceratto N, Panfoli I. Antioxidant role of metallothioneins: A comparative overview. Cell Mol Biol 2000; 46: 407-17.
142. Hartwig A. Carcinogenicity of metal compounds: Possible role of DNA repair inhibition. Toxicol Lett 1998; 102-103: 235-39.
143. Hartwig A, Mullenders LHF, Schlepegrell R, Kasten U, Beyersmann D. Nickel(II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 1994; 54: 4045-51.
144. Hayat L. Cations in malignant and benign brain tumors. J. Environ. Sci. Health. Part. A Environ Sci Eng Toxic Hazard Subst Control 1996; 31: 1831-40.
145. Milosevic N, Maier P. Lead stimulates intercelluar signaling between hepatocytes and Kupffer cells. Eur J Pharmacol 2000; 401: 317-28.
146. Krocova Z, Macela A, Kroca M, Hernychova I. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol In Vitro 2000; 14: 33-40.
147. Czauderna M, Rochalska M. Interaction between Se and Cr and distributiont of Zn, Rb, Co, and Fe in mice given chromate ions and selenium compounds. J Radioanal Nucl Chem 1989; 134: 383-92.
148. Blázovics A, Fehér E, Kéry Á, Petry G, Fehér J. Liver protecting and lipid lowering effects of Sempervivum tectorum in the rats. Phytother. Res 1993; 7: 98-100.
149. Blázovics A, Prónai L, Kéry Á, Petri G, Fehér J. Natural antioxidant extract from Sempervivum tectorum. Phytother Res 1993; 7: 95-97.
150. Blázovics A, González-Cabello R, Barta I, Gergely P, Fehér J. Effect of liver-protecting Sempervivum tectorum extract on the immune reactivity of spleen cells in hyperlipidemic rats. Phytother Res 1994; 8: 33-37.
151. Blázovics A, Lugasi A, Kemény T, Hagymási K, Kéry Á. Membrane stabilizing effects of natural polyphenols and flavonoids from S. tectorum on hepatic microsomal P450 system in hyperlipidemic rats. J Ethnopharm 2000; 73: 479-95.
152. Blázovics A, Lugasi A, Hagymási K, Szentmihályi K, Kéry A. Natural antioxidants, and tissue regeneration; Curative effet and reaction mechanism, In: Sigh E, and Govil JN Eds. Phytochemistry and Pharmacology IL SCI TECH Publishing LLC, Texas, USA 2002; 8: 93-34.
153. Czinner E, Lemberkovics É, Kéry Á, et al. Biologically active components of Helichrysum arenarium L. Eur J Drug Metab Pharmacokinet 1999; 24: 309-93.
154. Fejes Sz, Blázovics A, Lugasi A, Lemberkovics É, Petri G, Kéry A. Free radical scavenging and membrane protecting effect of methanol extracted fraction of Parsley. Acta Aliment (Hung) 2000; 29: 81-87.
155. Vági E, Rapavi E, Hadolin M, et al. Phenolic- and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. J. Agric. Food Chem 2005; 53: 17-21.
156. Horváth MÉ., Faux SP, Smith AG, et al. Cheeseman K. H.: Vitamin E protects against iron-hexachlorobenzene induced porphyria and formation of 8-hydroxy-deoxy guanoside in the liver of C57BL/10SeSa mice. Toxicology Lett 2001; 122: 97-02.
157. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for long cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-59.
158. Peterson K. "Natural" cancer prevention trial halted. Science 1996; 271: 441.
159. Kurosawa. (Grouppe Kurosawa Natural Medicines Blog) http://grouppekurosawa.com/blog/2005/04/ luteolin-now-readily-available.htm
160. Michaud DS, Feskanich D, Rimin EB, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutt 2000; 72: 990-97.
161. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. Dietary carotenoids, serum beta-carotene, and retinal and risk of long cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol 2002; 156: 536-47.
162. Schurman AG, Goldbohm RA, Brants HA, et al. A prospective cohort study on intake of retinol, vitamin C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 2002; 6: 573-82.
163. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154-60.
164. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.
165. Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 2000; 72: 476-83.
166. Yang CS, Kim S, Yang YH, et al. Inhibition of carcinogenesis by tea. Bioavailability of tea polyphenols and mechanism of action. Proc Soc Exp Biol Med 1999; 220: 213-17.
167. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995; 155: 381-86.
168. Paolini M, Antelli A, Pozetti L, et al. Induction of cytochrome P450 enzymes and overgeneration of oxygen redicals in beta-carotene supplemented rats. Carcinogenesis 2001; 22: 1483-85.
169. Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 47-1.
170. Hagymási K, Blázovics A. Antioxidánsok a májvédelemben, (Antioxidants in the liver-protection) Orvosi Hetilap 2004; 145: 1421-25.
171. Paolini M, Pozzetti L, Pedulli GF, et al. The nature of prooxidant activity of vitamin C. Life Sci 1999; 64: 273-78.
172. Herbert V. Viewpoints does mega-C do more good than harm, or more harm than good? Nutr Today 1993; 28: 126-33.
173. Slater TF. Free radical scavengers, in (+)-cyanidanol-3 in diseases of the liver, international workshop In: Conn HO Ed, Academic Press Inc., New York 1981; 11-15.
174. Slater TF, Eakins MN. Interactions of (+)-cyanidanol-3 with free radical generating system, In: Bartelli A Ed. New Trends in the Therapy of Liver Diseases, Karger, Basel, Switzerland 1983; 84-89.
175. Blázovics A, Vereckei A, Comides A, Fehér J. The effect of (+) cyanidanol-3 on the Na+K +ATP-ase and Mg++ATP-ase activities of the rat brain in the presence and absence of ascorbic acid. Acta Physiol Hung 1989; 73: 9-14.
176. Jadoul M, De Plaen JF, Cosyns JP, van Ypersele de Stribou C. Adverse effects from traditional Chinese medicine. Lancet 1993; 341: 892-93.
177. Vanherweghem JL, Depierreux M, Tielemeans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-91.
178. But PPH. Need for correct identification of herbs in herbal poisoning. Lancet 1993; 34: 637.
179. Gartner E, Marschall PS, Filandrinos D, Potek AS, Smith TM. Complications resulting from the use of Chinese herbal medications containing undeclared presciption drugs. Arthritis Rheum 1995; 38: 614-17.
180. Azzi A. The role of alpha-tocopherol in preventing disease. Eur J Nutr 2004; 43(Suppl 1): 118-85.
181. Bhari AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane). down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptoxis. Blood 2003; 101: 1053-62.
182. Wheeler DE, Catravas JD, Odoms K, Denenberg A, Malhotra V, Wong HR. Epigallocatechin-3-gallate, a gree tea-derived polyphenol, inhibits IL-1β-dependent proinflammatory signal transduction in cultured respiratory epithehal cells. Am Soc Nutr Sci 2004; 134: 1039-44.
183. Lunec J, Herbert KE, Jones GDD, et al. Development of a quality control material for the measurement of 8-oxo-7,8-dihydro-2′-deoxyguanosine. An in vivo market of oxidative stress and comparison of results from different laboratories. Free Radic Res 2001; 33: 527-31.
184. Griffiths HR, Lunec J. Ascorbic acid in the 21st century: more than a simple antioxidant. Environ. Toxicol. Pharmacol 2001; 10: 173-82.
185. Hoyos B, Imam A, Korichneva I, et al. The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J Biol Chem 2002; 277: 23949-57.
186. Pailler-Rodde I, Garcin H, Higueret P. Effect of retinoids on protein kinase C activity and on the binding characteristics of the tri-iodothyronine nuclear receptor. J Endocrinol 1991; 128: 245-51.
187. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H. Retinoic acid-induced apoptosis in leukaemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nature Med 2001; 7: 680-86.
188. Zhang XK. Vitamin A and apoptosis in prostate cancer. Endocr Relat Cancer 2002; 9: 87-102.
189. Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-24.
190. Puskás F, Gergely P, Banki K, Perl A. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J 2000; 14: 1352-61.
191. Winkler BS, Orselli SM, Rex TS. The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Free Radic Biol Med 1994; 17: 333-49.
192. Rose RC, Bode AM. Comments on the glutathione-ascorbic acid redox couple. Free Radic Biol Med 1995; 18: 955-56.
193. May JM, Qu ZC, Whitesell RR, Cohb CE. Ascorbate recycling in human erythrocytes: Role of GSH in reducing dehydroascorbate. Free Radic Biol Med 1996; 20: 543-51.
194. Tsuchiya H, Bates CJ, Changes in collagen cross-link ratios in bone and urine of quinea pigs fed graded vitamin C: a functional index of vitammin C status. J Nurtr Biochem 1998; 9: 402-07.
195. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature (Lond.) 1979; 278: 737-38.
196. Cooke MS, Evans MD, Herbert KE, Lunec J. Urinary 8-oxo-2 deoxyguanosine: source, significance and supplements. (Review) Free Rad Res 2000; 32: 381-97.
197. Kaina B, Kiesel S, Grombacher T, Fritz G. Inducible protective functions of mammalian cells against DNA-damaging agents Period Biol 1998; 100: 339-44.
198. Li Q, Zhang L, Tsang B, Gardner K, Bostick-Bruton F, Reed E. Phorbolester exposure activates an AP-1-mediaied increase in ERCC-1 messenger RNA expression in human ovarian cells. Cell Mol Life Sci 1999; 55: 456-66.
199. Podlutsky AJ, Irina I. Dianova II, et al. Human DNA polymerase β initiates DNA synthesis during long-patch repair of reduced AP sites in DNA. The EMBO J 2001; 20: 1477-82.
200. Traber MG. The ABCs of vitamin E and ß-carotene absorption. Am J Clin Nutr 2004; 80: 3-4.
201. Traber MG, Burton G W, Hamilton R L. Vitamin E trafficking. Ann NY Acad Sci USA 2004; 1031: 1-12.
202. Han SN, Adolfason O, Lee C-K, Prolla TA, Ordovas J, Meydani SN. Vitamin E and Gene Expression in Immune Cells. Am NY Acad Sci 2004; 1031: 96-01.
203. Azzi A, Stocker A. Vitamin E: non-antioxidant roles. Prog Lipid Res 2000; 39: 231-35.
204. Azzi A, Gysin R, Kempná P, et al. Regulation of gene ecpression by alpha tocoppherol. Biol Chem 2004; 385: 585-61.
205. Komódi E, Nagy E, Balla, Gy, Balla J, Galli F, Varga Zs. Az α-, a γ-és a δ tokoferol hatásának vizsgálata MPA stimulálta neutrofileΚBen. (Examination of the effect of α-, γ-and δ tocopherols on MPA stimulated neutrophyles.) A Magyar Szabadgyök-Kutató Társaság III. Konferenciája, (III. Conference of the Hungarian Free Radical Research Society) Debrecen 2005; 28.
206. Wang M, Li YQ, Zhong N, et al. [Induction of uridine 5′-diphosphate-glucuronosyltransferase gene expression by sulforaphane and its mechanism: experimental study in human colon cancel cells] Zhonghua Yi Xue Za Zhi 2005; 85: 819-24.
207. Zhang Y, Li J, Tang L. Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress. Free Radic Biol Med 2005; 38: 70-77.
208. Xu K, Thornalley PJ. Studies an the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmacol 2000; 15: 60: 221-31.
209. Halliwell B, Zhao K, Whiteman M. The gastrointestinal tract: a major site of antioxident action? Free Radic Res 2000; 33: 819-30.
210. Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: Antioxidants or signaling molecules? Free Radic Biol Med 2004; 36: 838-49.
211. Hollman PCH. Bioavailability of flavonoids. Eur J Clin Nutr 1997; 51: S66-69.
212. Lugasi A. Potentially health-protective effects of flavonoids having food origin. Orv Hetil 2000; 141: 1751-60.
213. Spencer JPE, Schroeter H, Rechner AR, Rice-Evans C. Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid Redox Signal 2001; 3: 1023-39.
214. Spencer JPE, Kuhnle GG, Williams RJ, Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 2003; 372: 173-81.
215. Sakagami H, Jiang Y, Kusama K, et al. Cytotoxic activity of hydrolysable tannins against human oral tumor cell lines: A possible mechanism. Phytomedicine 2000; 7: 39-47.
216. Croson GE, Caon Z, Goeddel DV. NF-ΚB activation by interleukin-1 (IL-1) requires an IL-1 receptor associated rotein kinase activity. J Biol Chem 1995; 270: 16514-17.
217. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor-ΚB in cancer cells versus normal cells. Arch Biochem Biophys 2000; 376: 338-46.
218. Chen PC, Wheeler DS, Malhotra V, et al. A green tee-derived polyphenol, epigallocatechin-3-gallate, inhibits IΚB kinase activation and IL-8 gene expression. Inflammation 2002; 26: 233-31.
219. Sheehan M, Wong HR, Hake PW, Malhotra V, O'Connor M, Zingarelli B. Parthenolide, an inhibitor of the nuclear factor-kappa B pathway, ameliorates cardiovascular derangement and outcome in endotoxin shock in rodents. Mol Pharmacol 2002; 61: 953-63.
220. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcrition factor-ΚB. Mol Pharmacol 1997; 52: 465-72.
221. Agullo G, Gamet-Payrastre L, Manenti S, et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997; 53: 1649-57.
222. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B. Flavonoids and the inhibition of PKC and PI3-kinase. Gen Pharmacol 1999; 32: 279-86.
223. Kong AN, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 2000; 23: 1-16.
224. Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3 gallate neuroprotective action. J Biol Chem 2002; 277: 30574-80.
225. Spencer JPE, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/ PKB and ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability J Biol Chem 2003; 278: 34783-93.
226. Habtemariam S. Flavonoids as inhibitors or enhancers of the cytotoxicity of tunor necrosis factor α in L-929 tumor cells. J Nat Prod 1997; 60: 775-78.
227. Dunnick J, Hailey J R. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol 1992; 19: 423-31.
228. Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol, Free Radic Biol Med 1999; 27: 5/6 704-14.
229. Li HL, Wang AB, Huang Y, et al. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 2005; 38: 343-57.
230. Pervaiz S. Resveratrol: from grapevines to mammalian biology, FASEB J 2003; 17: 1975-85.
231. Sato M, Ray PS, Maulik G, et al. Myocardial protection with red wine extract. J Cardiovasc Pharmacol 2000; 35: 263-68.
232. Manna SK, Mukhopadhyay A, Aggarwal BB. IFN-α suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis. Immunology 2000; 165: 4927-34.
233. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000; 164: 6509-19.
234. Estrov Z, Shishodia S, Faderl S, et al. Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003; 102: 987-95.
235. Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a). anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kapaB, cyclooxygenase 2, and matrix ractalloprotease 9. Cancer Res 2002; 62: 4945-54.
236. Li X, Yu H, Graves LM, Earp HS. Protein kinase C and protein kinase A inhibit calcium-dependent but not stress dependent c-Jun-terminal kinase activation in rat liver epithelial cells. J Biol Chem 1997; 272: 14996-02.
237. Kagiyama S, Eguchi S, Inagami T, Zhang YC, Phillips MI. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 2002; 106: 909-12.
238. Crackower MA, Suzuki A, Shioi T, et al. Regulation of myocardial contractility and cell size by distict PI3K-PTEN signaling pathways. Cell 2002; 110: 737-49.
239. Rouet-Benzineb, P, Gontero B, Dreyfus P, Lafuma, C. Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Biol Cardiol 2000; 32: 1767-78.
240. Ikeda K, Negishi H, Yamori Y. Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 2003; 189: 55-61.
241. Hamilton TA, Major JA, Armstrong D, Tebo JM. Oxidized LDL modulates activation, of NFkappaB in mononuclear phagocytes by altering the degradation if Ikap-paBs. J Leukoc Biol 1998; 64: 667-74.
242. Pace-Asciak C R, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-09.
243. Kerry NL, Abbey M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 1997; 135: 93-02.
244. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998; 92: 996-02.
245. Potter JD. Cancer prevention: Epidemiology and experiment. Cancer Lett 1997; 114: 7-9.
246. Blázovics A, Kovács Á, Lugasi A. The effect of short and long term antioxidant treatments on redox homeostasis in experimental and clinical studies. In: Watkins SV, Ed., Nutrition Research Advances, Nova Science Publisher Inc. 2007; Chapter 4: 1-33.
247. Cronstein BN, Weissman G. Targets for atiinflammatory drugs. Annu. Rev. Pharmacol Toxicol 1995; 35: 449-62.
248. Straus DS, Pascual G, Li M, et al 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 2000; 25: 4844-9.
249. Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P, Bosca L. Inhibition of IkappaB kinase and IkappaB phosphorylartion by 15-deoxy-delta (12,14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol 2000; 20: 1692-98.
250. Hori M, Kita M, Torihashi S, et al. Up regulation of iNOS by COX2 in muscularis resident macrophage rat intestine stimulated with LPS. Am J Physiol 2001; 280: G930-38.
251. Whittel BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607-11.
252. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995; 1: 813-19.
253. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-2.
254. Takashima. T, Fujiwara Y, Higuchi K, et al. PPAR-γ ligands inhibit growth of human esophageal adenocarcinoma cells throught induction of apoptosis, cell-cycle arrest and reduction of ornitbine decarboxylase activity. Int J oncol 2001; 19: 465-71.
255. Fuhrer D. A nuclear receptor in thyroid malignancy: is PAX8/PPAR-γ the Holly Grail of follicular thyroid cancer? Eur J Endocrinol 2001; 144: 453-56.
256. Gebhardt R. Differential inhibition of protein kinases and matrix metalloproteinases by natural flavonoids, a general survey. Inaugural COST 926 Conference European Workshop, Cellular responses to bioactive plant compounds-implications for human healt, Budapest 2004.
257. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancer 1992; 339: 89-91.
258. Wei SJ, Botero A, Hirota K, et al. Thioredoxin nuclear-translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 2000; 60: 6688-95.
259. Wiesel P, Foster LC, Pellacani A, et al. Thioredoxin facilitates the induction of heme oxygenase-1 response to inflammatory mediators. J Biol Chem 2000; 275: 24840-46.
260. Karimpour S, Lou J, Lin LL, et al. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 2002; 21: 6317-27.
261. Vacaresse N, Vieira O, Robbesy F, Junges G, Salvayre Negre-Salvayre A. Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation. Br J Pharmacol 2001; 132: 1777-88.